Stock Earnings

Question 1

Allergy Therapeutics PLCの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Allergy Therapeutics PLCの総資産は$64で、純lossは$-40です。

Question 2

AGYTFの主要な財務比率は何ですか？

Accepted Answer

Allergy Therapeutics PLCの流動比率は1.04、純利益率は-72.72、1株当たり売上高は$0.01です。

Question 3

Allergy Therapeutics PLCの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Allergy Therapeutics PLC largest revenue segment is Allergy-related Medicines, at a revenue of 55,199,000 in the most earnings release.For geography, Germany is the primary market for Allergy Therapeutics PLC, at a revenue of 27,047,510.

Question 4

Allergy Therapeutics PLCは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、Allergy Therapeutics PLCの純lossは$-40です。

Question 5

Allergy Therapeutics PLCに負債はありますか？

Accepted Answer

yes、Allergy Therapeutics PLCの負債は61です。

Question 6

Allergy Therapeutics PLCの発行済株式数は何株ですか？

Accepted Answer

Allergy Therapeutics PLCの総発行済株式数は4,766.43株です。

Breakdown	TTM	06/30/2024	06/30/2023	06/30/2022	06/30/2021	06/30/2020
Revenue	55	55	59	72	84	78
Revenue Growth (YoY)	4%	-7%	-18%	-14%	8%	7%
Cost of Revenue	25	25	26	23	22	20
Gross Profit	30	29	33	49	62	58
Selling, General & Admin	40	42	48	46	45	44
Research & Development	19	22	20	15	12	9
Operating Expenses	58	63	68	61	58	49
Other Non Operating Income (Expenses)	--	0	0	0	0	0
Pretax Income	-35	-39	-41	-12	3	8
Income Tax Expense	0	1	1	1	0	1
Net Income	-35	-40	-43	-13	2	7
Net Income Growth	-30%	-7%	231%	-750%	-71%	133%
Shares Outstanding (Diluted)	4,766.44	3,743.33	1,456.28	1,396.83	1,469.97	673.49
Shares Change (YoY)	75%	157%	4%	-5%	118%	1%
EPS (Diluted)	0	-0.01	-0.02	0	0	0.01
EPS Growth	-74%	-64%	199%	-595%	-81%	102%
Free Cash Flow	-32	-35	-33	-17	5	9
Free Cash Flow Per Share	0	0	-0.02	-0.01	0	0.01
Gross Margin	54.54%	52.72%	55.93%	68.05%	73.8%	74.35%
Operating Margin	-50.9%	-61.81%	-57.62%	-16.66%	4.76%	10.25%
Profit Margin	-63.63%	-72.72%	-72.88%	-18.05%	2.38%	8.97%
Free Cash Flow Margin	-58.18%	-63.63%	-55.93%	-23.61%	5.95%	11.53%
EBITDA	-24	-30	-30	-8	8	11
EBITDA Margin	-43.63%	-54.54%	-50.84%	-11.11%	9.52%	14.1%
D&A For EBITDA	4	4	4	4	4	3
EBIT	-28	-34	-34	-12	4	8
EBIT Margin	-50.9%	-61.81%	-57.62%	-16.66%	4.76%	10.25%
Effective Tax Rate	0%	-2.56%	-2.43%	-8.33%	0%	12.5%

Allergy Therapeutics PLC (AGYTF) Price

AGYTF Stock Price Chart

AGYTF Income

Follow-Up Questions